問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Tri-Service General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2022-01-05 - 2026-09-19
Condition/Disease
Test Drug
Participate Sites6Sites
Not yet recruiting1Sites
Recruiting5Sites
2024-01-01 - 2025-09-30
Participate Sites5Sites
2019-06-01 - 2022-12-31
Differentiated Thyroid Cancer
Cabozantinib (XL184) 20mg and 60mg tablet
Participate Sites4Sites
Recruiting4Sites
2019-03-01 - 2021-02-28
Metastatic Prostate Cancer
Oradoxel (Docetaxel + HM30181)
Participate Sites3Sites
Recruiting3Sites
全部
